O'Sullivan Miriam 4

Accession 0001225208-25-001876

CIK 0000885725other

View on SEC.gov Company Profile

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 5:52 PM ET

Size

40.6 KB

Accession

0001225208-25-001876

Insider Transaction Report

Form 4

Period: 2025-02-13

BOSTON SCIENTIFIC CORPBSX

O'Sullivan Miriam

SVP, Chief HR Officer

Transactions

Tax Payment
Common Stock
2025-02-16$106.11/sh−291$30,878→ 14,071 total
Exercise/Conversion
Common Stock
2025-02-17+1,000→ 15,071 total
Tax Payment
Common Stock
2025-02-17$106.11/sh−294$31,196→ 14,777 total
Exercise/Conversion
Common Stock
2025-02-14+106→ 1,650 total(indirect: By Spouse)
Tax Payment
Common Stock
2025-02-14$106.11/sh−38$4,032→ 1,612 total(indirect: By Spouse)
Exercise/Conversion
Common Stock
2025-02-16+85→ 1,697 total(indirect: By Spouse)
Tax Payment
Common Stock
2025-02-16$106.11/sh−30$3,183→ 1,667 total(indirect: By Spouse)
Exercise/Conversion
Common Stock
2025-02-17+100→ 1,767 total(indirect: By Spouse)
Tax Payment
Common Stock
2025-02-17$106.11/sh−36$3,820→ 1,731 total(indirect: By Spouse)
Award
Restricted Stock Units
2025-02-13+2,355→ 2,355 total
Exp: 2029-02-13→ Common Stock (2,355 underlying)
Exercise/Conversion
Common Stock
2025-02-14+1,123→ 13,702 total
Tax Payment
Common Stock
2025-02-14$106.11/sh−330$35,016→ 13,372 total
Exercise/Conversion
Common Stock
2025-02-16+990→ 14,362 total
Award
Stock Option (Right to Buy)
2025-02-13+6,061→ 6,061 total
Exercise: $106.14Exp: 2035-02-13→ Common Stock (6,061 underlying)
Exercise/Conversion
Restricted Stock Units
2025-02-14−1,123→ 2,248 total
Exp: 2027-02-14→ Common Stock (1,123 underlying)
Exercise/Conversion
Restricted Stock Units
2025-02-16−990→ 990 total
Exp: 2026-02-16→ Common Stock (990 underlying)
Exercise/Conversion
Restricted Stock Units
2025-02-17−1,000→ 0 total
Exp: 2025-02-17→ Common Stock (1,000 underlying)
Award
Restricted Stock Units
2025-02-13+188→ 188 total(indirect: By Spouse)
Exp: 2029-02-13→ Common Stock (188 underlying)
Exercise/Conversion
Restricted Stock Units
2025-02-14−106→ 212 total(indirect: By Spouse)
Exp: 2027-02-14→ Common Stock (106 underlying)
Exercise/Conversion
Restricted Stock Units
2025-02-16−85→ 85 total(indirect: By Spouse)
Exp: 2026-02-16→ Common Stock (85 underlying)
Exercise/Conversion
Restricted Stock Units
2025-02-17−100→ 0 total(indirect: By Spouse)
Exp: 2025-02-17→ Common Stock (100 underlying)

Footnotes (6)

[F1]Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
[F2]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
[F3]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
[F4]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.
[F5]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
[F6]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.

Documents

1 file

4
doc4.xmlPrimary

Issuer

BOSTON SCIENTIFIC CORP

CIK 0000885725

→

Entity typeother

Related Parties

filerCIK 0002048285

Filing Metadata

Form type: 4
Filed: Feb 17, 7:00 PM ET
Accepted: Feb 18, 5:52 PM ET
Size: 40.6 KB

View on SEC.gov